A subset of patients with MSS/MSI‑low‑colorectal cancer showed increased CD8(+) TILs together with up‑regulated IFN‑γ
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer - ScienceDirect
Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy | Journal for ImmunoTherapy of Cancer
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis | British Journal of Cancer
Cancers | Free Full-Text | Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
Cancers | Free Full-Text | Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
Microsatellite Stability - MSS Biomarker | Colorectal Cancer Alliance
Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
New hope on the horizon for patients with metastatic colorectal cancer | Colorectal Cancer
Frontiers | Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
Identification of two intrinsic epithelial subtypes of colorectal cancer | Nature Genetics
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
Immunotherapy in colorectal cancer: current achievements and future perspective
IJMS | Free Full-Text | The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
CCIs in colon cancer with MSS and MSI. The directions and number of... | Download Scientific Diagram
Optimizing Immunotherapy Combinations in Mismatch Repair–Proficient/Microsatellite-Stable Metastatic Colorectal Cancer
The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study - eClinicalMedicine
Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells
Stomach and colorectal cancer: AI identifyies patients for immunotherapy • healthcare-in-europe.com
Frontiers | Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability - ScienceDirect
Microsatellite Stability (MSS) | Know Your Biomarker
MSI-H Biomarker | Colorectal Cancer Alliance
Distribution of MSI-L/MSS colorectal cancers according to the number of... | Download Scientific Diagram
